Representatives of companies including AbbVie, Eli Lilly, Johnson & Johnson and Merck have voiced concerns about the FDA’s ...
Today, ProPublica is launching Rx Inspector, a first-of-its-kind database that provides answers to what the FDA won’t tell us ...
The FDA is considering reducing its routine food safety inspections and shifting more responsibility to state agencies. However, critics are concerned that this action could undermine oversight and ...
The Food and Drug Administration is developing a plan to shift more food safety inspection responsibility to state agencies over the course of five years, according to two sources familiar with ...
Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...
Catalent’s sweeping workforce reductions within its Maryland gene therapy manufacturing operations were preceded by two FDA inspections in April that resulted in red flags from the agency, FDA fili | ...
Some staff members say they are frustrated with the direction of inspections under new FDA Commissioner Dr Marty Makary. HealthDay News — The official in charge of federal food and drug safety ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...
Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it ...
His departure comes at a time of many concerns within the agency, including staff frustrations with the direction of inspections under new FDA Commissioner Dr Marty Makary. HealthDay News — The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback